Mar 4, 2026 03:00AM
Nov 12, 2025 06:02PM
Nov 4, 2025 04:01PM
Aug 13, 2025 04:31PM
Aug 13, 2025 04:31PM
Aug 13, 2025 04:15PM
Aug 6, 2025 08:00AM Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
Aug 6, 2025 08:00AM
May 7, 2025 04:58PM
May 7, 2025 04:45PM
May 2, 2025 08:30AM
May 2, 2025 08:30AM
Mar 26, 2025 06:34PM
Feb 24, 2025 08:00AM Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET
Nov 13, 2024 04:05PM
Oct 30, 2024 08:30AM
Aug 15, 2024 04:30PM
Aug 15, 2024 06:15AM
Aug 15, 2024 04:30AM
Aug 1, 2024 04:01PM
Jul 22, 2024 06:31AM Alvotech (ALVO) and STADA launch Uzpruvo
Jul 22, 2024 06:30AM
Jul 1, 2024 05:46AM
Jul 1, 2024 05:10AM
May 13, 2024 08:00AM
May 13, 2024 08:00AM
Apr 16, 2024 05:54PM
Apr 16, 2024 05:43PM Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Apr 16, 2024 05:30PM
Mar 5, 2024 04:00PM
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Feb 23, 2024 08:15PM
Nov 28, 2023 04:19PM
Nov 28, 2023 04:15PM Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Nov 21, 2023 08:00AM
Aug 22, 2023 09:15AM
Aug 6, 2023 09:00PM
Jul 31, 2023 09:00PM
Jun 30, 2023 09:00PM
Jun 19, 2023 09:00PM
May 19, 2023 05:45AM Alvotech (ALVO) Reports Q1 Loss of $1.24
May 19, 2023 05:00AM
Mar 1, 2023 04:30PM
Feb 27, 2023 07:15PM
Feb 27, 2023 07:15PM
Feb 9, 2023 02:30AM
Feb 9, 2023 02:30AM
Dec 7, 2022 04:00AM Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe
Dec 7, 2022 04:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All